It also impairs proteasomal degradation of Tau and results in the accumulation of high-molecular-weight Tau neurofibrillary tangles, linking LRRK2 to dementia in PD and Alzheimer’s disease [128]. The gene discussed is MAPT; the disease is Parkinson disease.